Abstract

cis-Diamminedichloroplatinum(II) (cisplatin) is used against different kinds of cancers. Unfortunately, because of the severe side-effects like nephrotoxicity, ototoxicity, etc., they are administered in small doses at low concentrations. The purpose of this work is to improve injectional controlled release (ICR) of cisplatin that releases drug in the extended temporal periods. In order to access this aim, biodegradable polymeric nanoparticles containing cisplatin as anticancer drug of various ranges from 71 to 661nm were prepared by a w/o/w double emulsion solvent evaporation technique. Influences of process parameters such as solvent removal technique, type and concentration of polymer, volume of oil phase, volume of external aqueous phase, concentration of stabilizer, drug concentration in the internal and external aqueous phases and power of sonication on morphology, characteristics of the nanoparticles and release profile were investigated. Morphology of the nanoparticles was studied by transmission electron microscopy (TEM) and scanning electron microscopy (SEM) and the images indicated that spherical shape of the nanoparticles can be tailored to rod-like shape by changing the reaction parameters. Size of the nanoparticles decreased as polymer concentration decreases. Volume of oil phase, power of sonication and drug concentration in the internal water phase affected the size of nanoparticles. Drug release profiles indicate that polymer concentration in the oil phase and stabilizer concentration in the external water phase have critical role in the drug release process from the nanoparticles. The in-vitro release of the encapsulated drug was observed by using the diffusion models of release from a sphere carrier and the release pattern was shown to be a complex process.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.